Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 925 of 3284 entries
View as:

A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients

Phase: N/A Priority: Normal
NCT ID: NCT06099236 Org: User:
Start: 01/15/24 End: 12/31/27 Due: 12/31/28

A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker

Phase: N/A Priority: Normal
NCT ID: NCT01137474 Org: User:
Start: 07/31/10 End: 02/28/13 Due: 02/28/14

Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT04385368 Org: User:
Start: 07/17/20 End: 08/31/23 Due: 08/31/24

TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)

Phase: N/A Priority: Normal
NCT ID: NCT05729711 Org: User:
Start: 04/04/23 End: 11/16/29 Due: 11/16/30

A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.

Phase: N/A Priority: Normal
NCT ID: NCT04495179 Org: User:
Start: 08/04/20 End: 08/08/22 Due: 08/08/23

A Study to Evaluate the Symptoms Over 24 Hours in Patients With Chronic Obstructive Pulmonary Disease - LASSYC Study

Phase: N/A Priority: Normal
NCT ID: NCT03381560 Org: User:
Start: 11/07/17 End: 06/30/18 Due: 06/30/19

Arimidex Therapy Compliance Electronic Monitoring System

Phase: N/A Priority: Normal
NCT ID: NCT00936442 Org: User:
Start: 06/30/09 End: 12/31/10 Due: 12/31/11

A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05951959 Org: User:
Start: 12/13/23 End: 07/07/28 Due: 07/07/29

Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients

Phase: N/A Priority: Normal
NCT ID: NCT06635447 Org: User:
Start: 09/26/24 End: 10/31/26 Due: 10/31/27

Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DM

Phase: N/A Priority: Normal
NCT ID: NCT06327815 Org: User:
Start: 03/15/24 End: 06/30/25 Due: 06/30/26

Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03682068 Org: User:
Start: 09/27/18 End: 04/29/26 Due: 04/29/27

A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations

Phase: N/A Priority: Normal
NCT ID: NCT05801029 Org: User:
Start: 07/18/23 End: 10/01/27 Due: 10/01/28

Study to Assess the Pharmacokinetics of AZD6140 After Single Dose in Healthy Japanese Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01588626 Org: User:
Start: 05/31/12 End: 06/30/12 Due: 06/30/13

'OLAP' (OLAparib Regulatory Post-marketing Surveillance)

Phase: N/A Priority: Normal
NCT ID: NCT04553926 Org: User:
Start: 02/01/21 End: 08/31/25 Due: 08/31/26

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

Phase: N/A Priority: Normal
NCT ID: NCT06960577 Org: User:
Start: 05/15/25 End: 10/31/28 Due: 10/31/29

A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a New Propellant (HFO) in Participants 40 to 80 Years of Age With COPD

Phase: N/A Priority: Normal
NCT ID: NCT06075095 Org: User:
Start: 01/11/24 End: 08/19/25 Due: 08/19/26

A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03742102 Org: User:
Start: 12/21/18 End: 02/26/27 Due: 02/26/28

A Study to Evaluate the Clinical Epidemiology of Patients With Heart Failure (HF) in India

Phase: N/A Priority: Normal
NCT ID: NCT02047526 Org: User:
Start: 11/30/13 End: - Due: -

Upper GI Symptoms In Patients Receiving Acetylsalicylic Acid/NSAIDs - NSAIDs Wave 2

Phase: N/A Priority: Normal
NCT ID: NCT00691743 Org: User:
Start: 03/31/08 End: 12/31/08 Due: 12/31/09

Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD6234

Phase: N/A Priority: Normal
NCT ID: NCT06845813 Org: User:
Start: 02/24/25 End: 01/08/26 Due: 01/08/27

Tezspire Cardiac Events PASS

Phase: N/A Priority: Normal
NCT ID: NCT06951867 Org: User:
Start: 09/15/25 End: 05/31/29 Due: 05/31/30

Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)

Phase: N/A Priority: Normal
NCT ID: NCT00305487 Org: User:
Start: 03/31/06 End: 10/31/06 Due: 10/31/07

Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01894243 Org: User:
Start: 03/13/14 End: 03/30/17 Due: 03/30/18

An ADME Study of [14C]AZD4604 and the Absolute Bioavailability of AZD4604

Phase: N/A Priority: Normal
NCT ID: NCT06157255 Org: User:
Start: 02/16/24 End: 05/20/24 Due: 05/20/25

Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD9291 in Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02096679 Org: User:
Start: 05/31/14 End: 08/31/14 Due: 08/31/15